We are live on ! Find out more
OIM

Oracle Investment Management Portfolio holdings

AUM $168M
1-Year Est. Return 42.86%
This Fund
S&P 500
This Quarter Est. Return
+21.29%
1 Year Est. Return
+42.86%
3 Year Est. Return
+864.89%
5 Year Est. Return
+1,153.35%
10 Year Est. Return
+22,228.86%
AUM
$876M
AUM Growth
+$149M
Cap. Flow
+$49.5M
Cap. Flow %
5.66%
Top 10 Hldgs %
74.66%
Holding
31
New
6
Increased
6
Reduced
8
Closed
1

Top Buys

Rank Stock Value
1
RPRX
Repros Therapeutics Inc.
RPRX
+$24M
2
IRWD icon
Ironwood Pharmaceuticals
IRWD
+$10.3M
3
ECYT
Endocyte, Inc. Common Stock
ECYT
+$9.71M
4
HNSN
HANSEN MEDICAL, INC. COM NEW
HNSN
+$7.27M
5
DSCI
Derma Sciences, Inc. Common Stock (DE)
DSCI
+$6.46M

Top Sells

Rank Stock Value
1
THOR
THORATEC CORPORATION
THOR
+$11.3M
2
GTIV
GENTIVA HEALTH SERVICES INC
GTIV
+$7.67M
3
MAKO
MAKO SURGICAL CORP COM
MAKO
+$4.54M
4
TSRO
TESARO, Inc.
TSRO
+$4.23M
5
OPK icon
Opko Health
OPK
+$1.46M

Sector Composition

Rank Sector Weight
1 Healthcare 73.01%
2 Consumer Staples 0.25%
3 Financials 0.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIIB icon
26
Biogen
BIIB
$30.8B
$3.53M 0.4%
11,530
-73
-0.6% -$23.2K
YTEN
27
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
$2.16M 0.25%
29
– –
ONCT
28
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$762K 0.09%
356
– –
LTS
29
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
$504K 0.06%
166,849
– –
GILD icon
30
Gilead Sciences
GILD
$168B
$99K 0.01%
+50,000
New +$3.92M
MAKO
31
DELISTED
MAKO SURGICAL CORP COM
MAKO
– –
-151,398
Closed -$4.54M
1
2

Similar funds

BIO
Blue Investment Opportunities Miami Beach, Florida $168M AUM 21.32% 1-Year Est. Return
OBWA
Oak Barrel Wealth Advisory Reston, Virginia $167M AUM
EECFX
EnCap Energy Capital Fund XII Houston, Texas $169M AUM
PW
Pandora Wealth Oakbrook Terrace, Illinois $165M AUM 18.5% 1-Year Est. Return
PWA
Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return
AIMU
Allianz Investment Management US Minneapolis, Minnesota $160M AUM 4.75% 1-Year Est. Return
HIA
Harvest Investment Advisors Tallahassee, Florida $176M AUM
ACA
AG Campbell Advisory Baltimore, Maryland $158M AUM

Oracle Investment Management's Q1 2014 Portfolio in Review

As of Q1 2014, Oracle Investment Management held 31 positions worth $876M, up 21% from $726M the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Oracle Investment Management deployed $49.5M of net new capital in Q1 2014, opening 6 new positions and adding to 6 existing holdings. Its largest new stake was Repros Therapeutics Inc.: 1,242,326 shares worth $22M.

By sector, the portfolio is most concentrated in Healthcare at 73% of assets, up from 68% a quarter earlier, followed by Consumer Staples and Financials.

On the sell side, the largest reduction was THORATEC CORPORATION, an estimated $11.3M trimmed.

  • Oracle Investment Management's largest Q1 2014 buy was Repros Therapeutics Inc.: 1,242,326 shares worth $22M.
  • Oracle Investment Management added most to Ironwood Pharmaceuticals in Q1 2014, an estimated $10.3M increase.
  • Oracle Investment Management's biggest Q1 2014 reduction was THORATEC CORPORATION, cutting an estimated $11.3M.
  • Oracle Investment Management fully exited MAKO SURGICAL CORP COM in Q1 2014, selling an estimated $4.54M.
  • Oracle Investment Management's ten largest holdings make up 75% of its $876M portfolio in Q1 2014.
  • Oracle Investment Management opened 6 new positions and closed 1 in Q1 2014.
  • Oracle Investment Management's portfolio value rose 21% quarter-over-quarter to $876M.

Based on Oracle Investment Management's 13F filing for Q1 2014, filed 15 May 2014.